CurrentEndo
Get Weekly

CurrentEndo coverage · page 6 of 12

Diabetes Technology & Therapeutics

Briefs 201–240 of 475 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes Technology & Therapeutics

All coverage, newest first

  1. Diabetes Technol Ther

    Algorithm-Driven Initiation and Adaptation of Hybrid Closed-Loop in Young Children with Type 1 Diabetes: A Pilot Study

    Research articleT1D

  2. Diabetes Technol Ther

    Glucose Control in Type 1 Diabetes after Pancreas Transplantation: Does Automated Delivery Offer Comparable Results?

    Cohort studyT1D

  3. Diabetes Technol Ther

    Personalized Hemoglobin A1c Shows Better Correlation with Mean Glucose than Laboratory Hemoglobin A1c in Ugandan Youth with Type 1 Diabetes, but Mean Glucose Is Not Clinically Useful in This Population Due to Extreme Glucose Variability

    Cohort studyT1D

  4. Diabetes Technol Ther

    The Importance of Instigating Automated Insulin Delivery Systems at Onset of Type 1 Diabetes: 1-Year Follow-Up of Children and Adolescents from Two Tertiary Pediatric Diabetes Centers

    Cohort studyT1D

  5. Diabetes Technol Ther

    Accuracy of the 15.5-Day G7 iCGM in Adults with Diabetes

    Diagnostic or prognostic studyTechnology

  6. Diabetes Technol Ther

    Open-Source Versus Commercial Automated Insulin Delivery System for Type 1 Diabetes Management: A Prospective Observational Comparative Study from Canada

    Cohort studyTechnology

  7. Diabetes Technol Ther

    Accuracy of Two Continuous Glucose Monitors Differs after Hydroxyurea in Pediatric Patients Undergoing Total Pancreatectomy with Islet Autotransplantation

    Diagnostic or prognostic studyTechnology

  8. Diabetes Technol Ther

    Evaluating the Adequacy of Coefficient of Variation and Standard Deviation as Metrics of Glucose Variability in Type 1 Diabetes Based on Data from the GOLD and SILVER Trials

    Secondary analysisT1D

  9. Diabetes Technol Ther

    Continuous Glucose Monitoring Use in Youth with Type 2 Diabetes: A Pilot Randomized Study

    Randomized controlled trialT2D & other

  10. Diabetes Technol Ther

    Use of Glucose Monitoring Devices Among Adults with Diabetes in Germany: Results from Nationwide Surveys Conducted in 2017 and 2021/2022

    Cross-sectional studyTechnology

  11. Diabetes Technol Ther

    Automated Insulin Delivery Versus Standard of Care in the Management of People Living with Type 1 Diabetes and HbA1c <8%: A Cost–Utility Analysis in The Netherlands

    Research articleTechnology

  12. Diabetes Technol Ther

    Impact of Meal Insulin Bolus Timing and Bedtime Snacking on Continuous Glucose Monitoring–Derived Glycemic Metrics in Hospitalized Inpatients

    Secondary analysisT2D & other

  13. Diabetes Technol Ther

    Automated Insulin Delivery in Elderly with Type 1 Diabetes: A Prespecified Analysis of the Extension Phase

    Secondary analysisT1D

  14. Diabetes Technol Ther

    Continuous Glucose Monitoring in Type 1 Diabetes, Type 2 Diabetes, and Diabetes During Pregnancy: A Systematic Review with Meta-Analysis of Randomized Controlled Trials

    Meta-analysisT1D

  15. Diabetes Technol Ther

    Continuous Glucose Monitoring-Based Titration of Once-Weekly Insulin Icodec in Insulin-Naive Individuals with Type 2 Diabetes (ONWARDS 9): A Phase 3b, Multicenter, Single-Arm, Treat-to-Target Clinical Trial

    Research articleT2D & other

  16. Diabetes Technol Ther

    A 13-Week Single-Arm Evaluation of Inhaled Technosphere Insulin Plus Insulin Degludec for Adults with Type 1 Diabetes

    Research articleT1D

  17. Diabetes Technol Ther

    Cardiovascular and Renal Biomarkers in Overweight and Obese Adults with Type 1 Diabetes Treated with Tirzepatide for 21 Months

    Cohort studyObesity

  18. Diabetes Technol Ther

    Inhaled Technosphere Insulin Plus Insulin Degludec for Adults with Type 1 Diabetes: The INHALE-3 Extension Study

    Randomized controlled trialT1D

  19. Diabetes Technol Ther

    The Association of Time-in-Range and Time-in-Tight-Range with Retinopathy Progression in the Virtual Diabetes Control and Complications Trial Continuous Glucose Monitoring Dataset

    Secondary analysisComplications

  20. Diabetes Technol Ther

    FRONTIER—FreeStyle Libre System Use in Ontario Among People with Diabetes Mellitus in the IC/ES Database—Evidence from Real-World Practice: Patients Using Intensive Insulin

    Cohort studyTechnology

  21. Diabetes Technol Ther

    Omnipod5 Real-World Data from the First Pediatric Users’ Universal Coverage Under the UK National Health Service

    Cohort studyTechnology

  22. Diabetes Technol Ther

    Correlation Between A1c and Continuous Glucose Monitor Time in Range in a Cohort of Pediatric Patients with Type 1 Diabetes

    Cohort studyTechnology

  23. Diabetes Technol Ther

    Short-Term Diabetic Retinopathy Status in People with Type 1 Diabetes Commencing Automated Insulin Delivery

    Cohort studyComplications

  24. Diabetes Technol Ther

    The Role of a Continuous Glucose Monitoring-Derived Glycation Ratio in the Development of Microvascular Complications

    Cohort studyComplications

  25. Diabetes Technol Ther

    Age-Dependent Bolus Settings: Insulin-to-Carbohydrate Ratios and Insulin Sensitivity Factors in Pediatric Patients with Type 1 Diabetes on Conventional CSII in the DPV Registry

    Cross-sectional studyTechnology

  26. Diabetes Technol Ther

    Safety and Effectiveness of MiniMed TM 780G Advanced Hybrid Closed-Loop Insulin Intensification in Adults with Insulin-Requiring Type 2 Diabetes

    Research articleT2D & other

  27. Diabetes Technol Ther

    Teens with Type 1 Diabetes and Executive Function Challenges Who Use Insulin Pumps Have Lower A1C Without Increased Risk of Diabetic Ketoacidosis or Severe Hypoglycemia

    Cohort studyT1D

  28. Diabetes Technol Ther

    Quantitative Comparison of Glucagon-Like Peptide-1 Receptor Agonists on Weight Loss in Adults: A Systematic Review and Model-Based Meta-Analysis

    Meta-analysisObesity

  29. Diabetes Technol Ther

    Accuracy of the Dexcom G7 Continuous Glucose Monitoring Sensors in People with Diabetes Undergoing Hemodialysis (ALPHA-2 Study)

    Diagnostic or prognostic studyTechnology

  30. Diabetes Technol Ther

    EValuating Glucose ContrOL Using a Next-GeneraTION Automated Insulin Delivery Algorithm in Patients with Type 1 and Type 2 Diabetes: The EVOLUTION Study

    Research articleTechnology

  31. Diabetes Technol Ther

    Evaluation of Accuracy and Safety of the 365-Day Implantable Eversense Continuous Glucose Monitoring System: The ENHANCE Study

    Diagnostic or prognostic studyTechnology

  32. Diabetes Technol Ther

    Long-Term Improvements in Glycemia and User-Reported Outcomes Associated with Open-Source Automated Insulin Delivery Systems in Adults with Type 1 Diabetes in the United Kingdom: A Real-World Observational Study

    Cohort studyTechnology

  33. Diabetes Technol Ther

    Glycemic Control Across the Menstrual Cycle in Women with Type 1 Diabetes Using the MiniMed 780G Advanced Hybrid Closed-Loop System: The 780MENS Prospective Study

    Cohort studyTechnology

  34. Diabetes Technol Ther

    Accuracy of Continuous Glucose Monitoring in Adults with Type 1 Diabetes Admitted to Hospital: A Real-World Multicenter Observational Study

    Cohort studyT1D

  35. Diabetes Technol Ther

    A Comparison of Glucose and Additional Signals for Three Different Exercise Types in Adolescents with Type 1 Diabetes Using a Hybrid Closed-Loop System

    Research articleTechnology

  36. Diabetes Technol Ther

    The Virtual DCCT: Adding Continuous Glucose Monitoring to a Landmark Clinical Trial for Prediction of Microvascular Complications

    Secondary analysisT1D

  37. Diabetes Technol Ther

    Predicting and Ranking Diabetic Ketoacidosis Risk Among Youth with Type 1 Diabetes with a Clinic-to-Clinic Transferrable Machine Learning Model

    Diagnostic or prognostic studyT1D

  38. Diabetes Technol Ther

    The Longer, the Better: Continuous Glucose Monitoring Use for ≥90% Is Superior to 70%–89% in Achieving Tighter Glycemic Outcomes in Children with Type 1 Diabetes

    Cohort studyTechnology

  39. Diabetes Technol Ther

    A Glucose Fraction Independent of Insulin Secretion: Implications for Type 1 Diabetes Progression in Autoantibody-Positive Cohorts

    Secondary analysisT1D

  40. Diabetes Technol Ther

    A Randomized Controlled Trial Using Continuous Glucose Monitoring to Guide Food Choices and Diabetes Self-Care in People with Type 2 Diabetes not Taking Insulin

    Randomized controlled trialT2D & other

All 475 Briefs in ExploreShowing Briefs 201–240 of 475, newest first